Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Gastric Cancer (GC)”

121 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 121 results

Not applicableActive Not RecruitingNCT07184047
What this trial is testing

Frailty Scales for Predicting Chemotherapy Toxicity in Older Adults With Gastrointestinal Cancers

Who this might be right for
Gastrointestinal CancersFrailtySarcopenia in Elderly+8 more
Ankara Etlik City Hospital 72
Large-scale testing (Phase 3)Looking for participantsNCT04342910
What this trial is testing

Study to Evaluate the Efficacy and Safety of Camrelizumab and Apatinib in Patients With GC/GEJC

Who this might be right for
Gastric Cancer
Jiangsu HengRui Medicine Co., Ltd. 550
Not applicableLooking for participantsNCT07076979
What this trial is testing

Development and Validation of Metabolic Biomarkers for Early Diagnosis, Prognosis, and Recurrence of Gastric Cancer：MetBio-GC

Who this might be right for
Gastric Cancer
Shanghai Minimally Invasive Surgery Center 250
Testing effectiveness (Phase 2)Ended earlyNCT03061708
What this trial is testing

Trial of Single Agent AZD2014 in RICTOR Amplified GC Patients as Second-line Therapy

Who this might be right for
Stomach Neoplasms
Samsung Medical Center 1
Not applicableLooking for participantsNCT07313579
What this trial is testing

Hyperthermic Intraperitoneal Chemoperfusion (HIPEC) in Gastric Cancer

Who this might be right for
Gastric Cancer (GC)HIPECPeritoneal Metastases From Gastric Cancer+1 more
Ukrainian Society of Clinical Oncology 200
Testing effectiveness (Phase 2)Looking for participantsNCT07315854
What this trial is testing

Iparomlimab and Tuvonralimab (QL1706) Combined With Chemotherapy for Previously Untreated Advanced or Metastatic Gastric or Gastroesophageal Junction Cancer

Who this might be right for
Gastric Cancer (GC)Gastroesophageal Junction CancerAdvanced Gastric Cancer+1 more
Beijing Friendship Hospital 32
Not applicableActive Not RecruitingNCT07403916
What this trial is testing

Influence of Age on the Choice of Treatment and Prognosis in Patients With Resectable Gastric Cancer

Who this might be right for
Gastric Cancer (GC)Next-generation SequencingMolecular Analysis
P. Herzen Moscow Oncology Research Institute 90
Not applicableStudy completedNCT06339307
What this trial is testing

A Prospective Clinical Study to Validate a Preoperative Risk Scoring Model for LNM in GC Patients

Who this might be right for
Predictive Cancer ModelGastric CancerLymph Node Metastasis
Tianjin Medical University Cancer Institute and Hospital 120
Testing effectiveness (Phase 2)Looking for participantsNCT07069712
What this trial is testing

Novel Agents or Combinations as Perioperative Treatment in Participants With Locally Advanced Resectable Gastroesophageal Adenocarcinoma

Who this might be right for
Gastroesophageal Adenocarcinoma
AstraZeneca 100
Testing effectiveness (Phase 2)Looking for participantsNCT04868877
What this trial is testing

Phase 1/2 Study Evaluating MCLA-129, a Human Anti-EGFR, Anti-c-MET Bispecific Antibody, in Advanced NSCLC and Other Solid Tumors, Alone and in Combination

Who this might be right for
Non-Small Cell Lung Cancer MetastaticGastric CancerEsophageal Squamous Cell Carcinoma+2 more
Merus B.V. 576
Not applicableActive Not RecruitingNCT07180966
What this trial is testing

Development and Validation of the Surgical Assessment and Healthcare (SAH) Index for Gastric Cancer Treatment Evaluation

Who this might be right for
Gastric Cancer (GC)
Ruijin Hospital 780
Large-scale testing (Phase 3)Not Yet RecruitingNCT07362186
What this trial is testing

LM-108 in Combination With Toripalimab Versus Paclitaxel Injection for the Treatment of Subjects With CCR8-Positive Gastric and Gastroesophageal Junction Adenocarcinoma

Who this might be right for
Locally Advanced or Metastatic GC and GCJ Adenocarcinoma
LaNova Medicines Limited 400
Testing effectiveness (Phase 2)UnknownNCT06046963
What this trial is testing

Sintilimab in Combination With S-1/Oxaliplatin With Nab-paclitaxel Intraperitoneal Infusion for Untreated Advanced Gastric Cancer With Malignant Ascites

Who this might be right for
Gastric CancerPeritoneal MetastasesAscites, Malignant
Zhejiang Cancer Hospital 35
Testing effectiveness (Phase 2)Active Not RecruitingNCT03979131
What this trial is testing

Phase II Study of Avelumab Plus Chemotherapy in the Peri-operative Treatment for Patients With Resectable Gastric Cancer (GC) or Gastroesophageal Junction Cancer (GEJC)

Who this might be right for
Gastroesophageal Junction AdenocarcinomaStomach Neoplasms
Vall d'Hebron Institute of Oncology 40
Testing effectiveness (Phase 2)UnknownNCT05942573
What this trial is testing

Continuation of Serplulimab Plus Chemotherapy After First Progression in Advanced Gastric or Gastro-oesophageal Junction Adenocarcinoma: an Open-label, Randomised Phase II Trial

Who this might be right for
Gastric Cancer (GC) Gastroesophageal Junction Cancer (GEJ)
Tianjin Medical University Cancer Institute and Hospital 107
Not applicableStudy completedNCT01420588
What this trial is testing

Diagnosis of Gastric Lesions From Exhaled Breath and Saliva

Who this might be right for
Stomach Diseases
Anhui Medical University 1,000
Not applicableLooking for participantsNCT04890171
What this trial is testing

Comparison of Endoscopic Resection and Surgery for Early Gastric Cancer With Undifferentiated Histological Type

Who this might be right for
Stomach CancerUndifferentiated TypeExpanded Indication of Endoscopic Resection
National Cancer Center, Korea 708
Early research (Phase 1)Study completedNCT00960349
What this trial is testing

Study of Cediranib Plus Cisplatin Plus Capecitabine/S-1 in Japanese Gastric Cancer Patients

Who this might be right for
Gastric Cancer
AstraZeneca 14
Very early researchEnrolling By InvitationNCT07023848
What this trial is testing

PET Image Exploration of 89Zr-labeled Antibody Fragments Targeting HER2 in Patients With Malignant Tumors

Who this might be right for
Breast CancerGastric Cancer (GC)Urothelial Carcinoma (UC)
Affiliated Hospital of Jiangnan University 10
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06980389
What this trial is testing

Node-Sparing Short-Course Radiotherapy Plus First-Line Therapy and PD-1 Inhibitor in Unresectable/Metastastic pMMR/MSS Gastric Cancer (MODIFI-GC)

Who this might be right for
Immune Checkpoint TherapyRadiotherapyMetastatic Gastric Carcinoma
Sixth Affiliated Hospital, Sun Yat-sen University 176
Load More Results